Improved MDCT monitoring of pelvic myeloma bone disease through the use of a novel longitudinal bone subtraction post-processing algorithm.
Horger M et al. Eur Radiol. 2016 Nov 23. [Epub ahead of print].
Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.
Sawyer JR et al. Leukemia. 2016 Nov 4. doi: 10.1038/leu.2016.253. [Epub ahead of print].
Predictors of inferior clinical outcome in patients with standard risk multiple myeloma.
Badar T et al. Eur J Haematol. 2016 Nov 9. doi: 10.1111/ejh.12826. [Epub ahead of print].
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.
Shi L et al. Oncotarget. 2016 Nov 12. doi: 10.18632/oncotarget.13320. [Epub ahead of print].
IgD-λ myeloma with extensive free light-chain excretion: a diagnostic pitfall in the identification of monoclonal gammopathies.
Robier C, et al. Clin Chem Lab Med. 2016 Nov 7. pii: /j/cclm.ahead-of-print/cclm-2016-0653/cclm-2016-0653.xml. doi: 10.1515/cclm-2016-0653. [Epub ahead of print].
Urinary NGAL for the diagnosis of the renal injury from multiple myeloma.
Du W et al. Cancer Biomark. 2016 Oct 28. [Epub ahead of print].
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide.
Pourabdollah M et al. J Hematol Oncol. 2016 Nov 21;9(1):123.
Adverse metaphase cytogenetics can be overcome by adding bortezomib and thalidomide to fractionated melphalan transplants.
Jethava Y et al. Clin Cancer Res. 2016 Nov 3. pii: clincanres.2620.2015. [Epub ahead of print].
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed withmultiple myeloma.
Kim DS et al. Korean J Intern Med. 2016 Nov 4. doi: 10.3904/kjim.2016.054. [Epub ahead of print].
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
Lindqvist EK et al. Ann Hematol. 2016 Nov 2. [Epub ahead of print].
Prognostic value of lactate dehydrogenase in Chinese patients with newly diagnosed transplant eligiblemultiple myeloma.
Huang B et al. Leuk Lymphoma. 2016 Nov 23:1-3. [Epub ahead of print].
Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.
Suehara Y et al. Cancer Sci. 2016 Nov 27. doi: 10.1111/cas.13125. [Epub ahead of print].